Gene · 2168
Papers3,436
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,436
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Quantitative proteomics analysis based on data-independent acquisition reveals the effect of Shenling Baizhu powder (SLP) on protein expression in MAFLD rat liver tissue. | Clin Proteomics | 2023 | 38036981 | PubTator, text mining | PubMed |
| Untargeted and spatial-resolved metabolomics characterize serum and tissue-specific metabolic reprogramming in acute kidney injury. | Heliyon | 2023 | 38027662 | PubTator, text mining | PubMed |
| MiR-337-3p improves metabolic-associated fatty liver disease through regulation of glycolipid metabolism. | iScience | 2023 | 38026196 | PubTator, text mining | PubMed |
| Single-cell RNA-sequencing atlas reveals an FABP1-dependent immunosuppressive environment in hepatocellular carcinoma. | J Immunother Cancer | 2023 | 38007237 | PubTator, text mining | PubMed |
| Changes in Cardiovascular and Renal Biomarkers Associated with SGLT2 Inhibitors Treatment in Patients with Type 2 Diabetes Mellitus. | Pharmaceutics | 2023 | 38004506 | PubTator, text mining | PubMed |
| COVID-19 and Kidney: The Importance of Follow-Up and Long-Term Screening. | Life (Basel) | 2023 | 38004277 | PubTator, text mining | PubMed |
| Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk. | Genes (Basel) | 2023 | 38003001 | PubTator, text mining | PubMed |
| Current Status of Protein Biomarkers in Urolithiasis-A Review of the Recent Literature. | J Clin Med | 2023 | 38002747 | PubTator, text mining | PubMed |
| Currently Used Methods to Evaluate the Efficacy of Therapeutic Drugs and Kidney Safety. | Biomolecules | 2023 | 38002263 | PubTator, text mining | PubMed |
| Cross-Sectional and Longitudinal Associations between Skin Autofluorescence and Tubular Injury Defined by Urinary Excretion of Liver-Type Fatty Acid-Binding Protein in People with Type 2 Diabetes. | Biomedicines | 2023 | 38002020 | PubTator, text mining | PubMed |
| Detecting host responses to microbial stimulation using primary epithelial organoids. | Gut Microbes | 2023 | 37992398 | PubTator, text mining | PubMed |
| Multifaceted relationship between diabetes and kidney diseases: Beyond diabetes. | World J Diabetes | 2023 | 37970131 | PubTator, text mining | PubMed |
| Progress Towards Understanding Cardiac Surgery Associated Kidney Injury in Children. | CJC Pediatr Congenit Heart Dis | 2023 | 37970103 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Expression and Prognosis for Lipid Metabolism-Related Genes in Hepatocellular Carcinoma. | South Asian J Cancer | 2023 | 37969675 | PubTator, text mining | PubMed |
| Treatment with recombinant Sirt1 rewires the cardiac lipidome and rescues diabetes-related metabolic cardiomyopathy. | Cardiovasc Diabetol | 2023 | 37957697 | PubTator, text mining | PubMed |
| Moving toward a contemporary classification of drug-induced kidney disease. | Crit Care | 2023 | 37946280 | PubTator, text mining | PubMed |
| Therapeutic effects of fatty acid binding protein 1 in mice with pulmonary fibrosis by regulating alveolar epithelial regeneration. | BMJ Open Respir Res | 2023 | 37940355 | PubTator, text mining | PubMed |
| The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approaches. | Basic Res Cardiol | 2023 | 37938421 | PubTator, text mining | PubMed |
| Structured Moderate Exercise and Biomarkers of Kidney Health in Sedentary Older Adults: The Lifestyle Interventions and Independence for Elders Randomized Clinical Trial. | Kidney Med | 2023 | 37915963 | PubTator, text mining | PubMed |
| Extracellular matrix modulates the spatial hepatic features in hepatocyte-like cells derived from human embryonic stem cells. | Stem Cell Res Ther | 2023 | 37907977 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2168/papers?page=16